Evidence map›Paper›PMID 33317443›Full record

ArticleMolecular medicine (Cambridge, Mass.)2020

Correction to: miRNA-23b as a biomarker of culture-positive neonatal sepsis.

Ahlam Fatmi, Sid Ahmed Rebiahi, Nafissa Chabni, Hanane Zerrouki, Hafsa Azzaoui, Yamina Elhabiri, Souheila Benmansour, José Santiago Ibáñez-Cabellos, Mohammed Chems-Eddine Smahi, Mourad Aribi and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ahlam FatmiLaboratory of Applied Molecular Biology and Immunology, W0414100, Tlemcen, Algeria.
Sid Ahmed RebiahiLaboratory of Microbiology Applied in Food, Biomedical and Environment, Tlemcen, Algeria.
Nafissa ChabniFaculty of Medicine, Tlemcen Medical Centre University, 13000, Tlemcen, Algeria.
Hanane ZerroukiLaboratory of Microbiology Applied in Food, Biomedical and Environment, Tlemcen, Algeria.
Hafsa AzzaouiLaboratory of Applied Molecular Biology and Immunology, W0414100, Tlemcen, Algeria.
Yamina ElhabiriLaboratory of Microbiology Applied in Food, Biomedical and Environment, Tlemcen, Algeria.
Souheila BenmansourLaboratory of Applied Molecular Biology and Immunology, W0414100, Tlemcen, Algeria.
José Santiago Ibáñez-CabellosCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain.
Mohammed Chems-Eddine SmahiLaboratory of Applied Molecular Biology and Immunology, W0414100, Tlemcen, Algeria.
Mourad AribiLaboratory of Applied Molecular Biology and Immunology, W0414100, Tlemcen, Algeria.
José Luis García-GiménezCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain.
Federico V PallardóCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain. federico.v.pallardo@uv.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33317443
PMCPMC7734705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.